Actinium Pharmaceuticals, Inc. (ATNM)
NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 03:27PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 55.14M |
| Enterprise Value | -29.04M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 614.52 |
| Price/Book (mrq) | 1.26 |
| Enterprise Value/Revenue | 1.73k |
| Enterprise Value/EBITDA | -3.62 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.15 |
| 52-Week Change 3 | -71.73% |
| S&P500 52-Week Change 3 | 26.76% |
| 52 Week High 3 | 10.2400 |
| 52 Week Low 3 | 1.3300 |
| 50-Day Moving Average 3 | 4.1254 |
| 200-Day Moving Average 3 | 6.2802 |
Share Statistics
| Avg Vol (3 month) 3 | 835.93k |
| Avg Vol (10 day) 3 | 370.43k |
| Shares Outstanding 5 | 31.15M |
| Implied Shares Outstanding 6 | 31.15M |
| Float 8 | 30.37M |
| % Held by Insiders 1 | 2.04% |
| % Held by Institutions 1 | 27.42% |
| Shares Short (Aug 30, 2024) 4 | 2.22M |
| Short Ratio (Aug 30, 2024) 4 | 1.32 |
| Short % of Float (Aug 30, 2024) 4 | 7.12% |
| Short % of Shares Outstanding (Aug 30, 2024) 4 | 7.12% |
| Shares Short (prior month Jul 31, 2024) 4 | 2.47M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Aug 11, 2020 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:30 |
| Last Split Date 3 | Aug 11, 2020 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -57,665.44% |
Management Effectiveness
| Return on Assets (ttm) | -30.91% |
| Return on Equity (ttm) | -87.96% |
Income Statement
| Revenue (ttm) | 81k |
| Revenue Per Share (ttm) | 0.00 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -46.48M |
| Net Income Avi to Common (ttm) | -42.62M |
| Diluted EPS (ttm) | -1.5100 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 86.04M |
| Total Cash Per Share (mrq) | 2.76 |
| Total Debt (mrq) | 1.85M |
| Total Debt/Equity (mrq) | 4.22% |
| Current Ratio (mrq) | 8.95 |
| Book Value Per Share (mrq) | 1.43 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33.96M |
| Levered Free Cash Flow (ttm) | -20.06M |
© 2024 Yahoo. All rights reserved.